Cocrystal Pharma, Inc. Share Price

Cocrystal Pharma, Inc. Share Price

NASDAQ: COCP | Micro Cap
$1.00
+$0.02 (2.30%) Last updated on 28 Oct, 2026 | 19:20 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cocrystal Pharma, Inc. Stock Performance

Open
$0.97
Prev. Close
$0.98
Circuit Range
N/A
Day Range
$0.97 - $1.00
Year Range
$0.87 - $1.99
Volume
307
Average Traded
$0.99

Cocrystal Pharma, Inc. Share Price Today

As of 31 October 2026, Cocrystal Pharma, Inc.'s share price is $1.00. The stock opened at $0.97, compared to its previous close of $0.98. During today's trading session, Cocrystal Pharma, Inc.'s share price traded between $0.97 and $1.00, with an average price of $0.99. Over the past 52 weeks, the stock has recorded a high of $1.99 and a low of $0.87. In terms of performance, Cocrystal Pharma, Inc.'s share price has declined by 30.07% over the last six months and is down 10.71% on a year-on-year basis.

Cocrystal Pharma, Inc. Share Price Chart

Line chart of the Cocrystal Pharma, Inc. price trend over the selected period. The price rose overall, ranging from 0.97 to 0.97, ending at 0.97.
$0.97$1.00
L
Show Current Price
H

Cocrystal Pharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$11.29M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.52
Revenue (TTM)
$0.00
Return On Equity (TTM)
-951.92%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-54.15%

Cocrystal Pharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.23$0.11
Net Profit-$2.05-$2.43-$2.30-$3.16
Net Profit MarginN/AN/A-1000.00%-2872.73%
Income ChangeN/A-18.54%5.35%-37.39%

Cocrystal Pharma, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$38.84-$17.98-$17.50-$8.83
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A53.71%2.67%49.54%

About Cocrystal Pharma, Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

Cocrystal Pharma, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.14
$1.00
-11.11%
Sep 2026
$1.14
$1.13
-2.17%
Aug 2026
$0.96
$1.15
+32.64%
Jul 2026
$1.06
$0.87
-17.03%
Jun 2026
$1.14
$1.04
-5.00%
May 2026
$1.41
$1.10
-23.08%
Apr 2026
$1.03
$1.43
+43.00%
Mar 2026
$1.02
$1.00
-4.76%
Feb 2026
$0.98
$1.05
+6.06%
Jan 2026
$0.99
$0.99
+2.06%
Dec 2025
$1.04
$0.97
+4.19%
Nov 2025
$1.06
$0.93
-16.88%

COCP Share Price FAQs